Cross-institution positioning
Mar 26, 2026Reduction leaning. 1 accumulating, 2 exited across 3 comparable institutions.
Source: Schedule 13 researchDAKTRONICS INC /SD/
Latest stored close $17.89 as of Oct 8, 2026 View live quote ↗
See how each tracked institution's reported ownership changed across SEC position dates. Full history is available with Investor or Pro access.
What the evidence shows across the newest institutional, insider, company-event, 13F, fundamental, and price data; STOCKNODE combines these layers into a quantitative research signal while preserving each source and reporting window.
Reduction leaning. 1 accumulating, 2 exited across 3 comparable institutions.
Source: Schedule 13 research2 increased/new, 0 reduced/exited across 2 managers in the latest comparable Form 13F quarter.
Source: Form 13F quarter-end holdingsOver the last 90 days, SEC-coded non-derivative P/S activity includes 0 purchases by 0 reporting owners and 1 sale by 1 reporting owner. Amendments are shown in the filing evidence but excluded from rolling activity totals.
Source: SEC Forms 3/4/54 non-amendment material events in the last 90 days; Latest classified evidence: Director or executive change. Registration and prospectus filings are treated as financing capacity/disclosure evidence, not proof that securities were sold.
Source: SEC 8-K / securities filing metadataRevenue +7.1% YoY; Net income +18.0% YoY. Periods are compared only when the SEC facts are aligned and comparable.
Source: SEC Company FactsRecent close is 6% through its reported 52-week range; -26.2% over one year.
Source: Stored historical price seriesFiled Mar 26, 2026. Unlock the dated position comparison, disclosure classification, confidence, price context, and filing-specific significance analysis.
Premium research values are withheld until unlocked.
The research summary above gives the current read. This section shows the dated holder-level evidence behind it.
See each institution's newest reported position against its own prior report, with position as-of date separated from SEC filed date. Institution names and filing freshness remain public below.
Comparable holder direction grouped by SEC position as-of date — never presented as trade dates.
Compare each institution only with its own prior reported position. Public visitors can see who is tracked and how fresh the filing is; paid research reveals the actual comparison.
Investor and Pro reveal holder-by-holder changes, reported ownership history, dated breadth, disclosure timing, institution comparison, and filing-specific analysis without treating Schedule 13 reports as trade dates.
Reported Section 16 ownership activity. Rolling purchase/sale totals use non-derivative SEC transaction codes P and S only; amendments remain visible but are excluded from those totals.
| Date | Reporting owner | Code | Security | Shares | Price | Ownership | Filed |
|---|---|---|---|---|---|---|---|
| Sep 21, 2026 | Atkins Howard I | AGrant, award, or other acquisition | Common Stock | 9.6K | $0.00 | Direct | Sep 23, 2026 |
| Sep 17, 2026 | Bowser Mark F | AGrant, award, or other acquisition | Common Stock | 6.6K | $0.00 | Direct | Sep 21, 2026 |
| Sep 17, 2026 | Friel John Patrick | AGrant, award, or other acquisition | Common Stock | 6.6K | $0.00 | Direct | Sep 21, 2026 |
| Sep 17, 2026 | Griffiths Jose-Marie | AGrant, award, or other acquisition | Common Stock | 6.6K | $0.00 | Direct | Sep 21, 2026 |
| Sep 17, 2026 | Glat Neil | AGrant, award, or other acquisition | Common Stock | 6.6K | $0.00 | Direct | Sep 21, 2026 |
| Sep 17, 2026 | BULTENA LANCE DEAN | AGrant, award, or other acquisition | Common Stock | 6.6K | $0.00 | Direct | Sep 21, 2026 |
| Sep 17, 2026 | Williams Shereta Diana | AGrant, award, or other acquisition | Common Stock | 6.6K | $0.00 | Direct | Sep 21, 2026 |
| Sep 17, 2026 | Feigin Peter | AGrant, award, or other acquisition | Common Stock | 6.6K | $0.00 | Direct | Sep 21, 2026 |
| Sep 17, 2026 | Siegel Andrew David | AGrant, award, or other acquisition | Common Stock | 6.6K | $0.00 | Direct | Sep 21, 2026 |
| Sep 5, 2026 | Wiemann Bradley T | MExercise or conversion of derivative · derivative | Restricted Stock Units | 1.4K | $0.00 | Direct | Sep 9, 2026 |
| Sep 5, 2026 | Wiemann Bradley T | MExercise or conversion of derivative · derivative | Restricted Stock Units | 492 | $0.00 | Direct | Sep 9, 2026 |
| Sep 5, 2026 | Wiemann Bradley T | MExercise or conversion of derivative · derivative | Restricted Stock Units | 500 | $0.00 | Direct | Sep 9, 2026 |
| Sep 5, 2026 | Wiemann Bradley T | FTax/price withholding or payment | Common Stock | 330 | $19.67 | Direct | Sep 9, 2026 |
| Sep 5, 2026 | Wiemann Bradley T | MExercise or conversion of derivative | Common Stock | 1.4K | — | Direct | Sep 9, 2026 |
| Sep 5, 2026 | Wiemann Bradley T | FTax/price withholding or payment | Common Stock | 118 | $19.67 | Direct | Sep 9, 2026 |
| Sep 5, 2026 | Wiemann Bradley T | MExercise or conversion of derivative | Common Stock | 492 | — | Direct | Sep 9, 2026 |
| Sep 5, 2026 | Wiemann Bradley T | FTax/price withholding or payment | Common Stock | 121 | $19.67 | Direct | Sep 9, 2026 |
| Sep 5, 2026 | Wiemann Bradley T | MExercise or conversion of derivative | Common Stock | 500 | — | Direct | Sep 9, 2026 |
| Aug 23, 2026 | Jayaraman Ramesh | MExercise or conversion of derivative · derivative | Restricted Stock Units | 7.1K | $0.00 | Direct | Aug 25, 2026 |
| Aug 23, 2026 | Jayaraman Ramesh | FTax/price withholding or payment | Common Stock | 1.7K | $19.00 | Direct | Aug 25, 2026 |
Recent 8-K item classifications plus securities registration and prospectus filings. Registration or prospectus filings show financing capacity/disclosure activity; they do not by themselves prove that securities were sold.
| Filed | Form | 8-K item(s) | Classification | Capital context | SEC |
|---|---|---|---|---|---|
| Sep 18, 2026 | 8-K | 5.02, 5.07, 9.01 | Director or executive change; Shareholder vote results; Financial statements / exhibits | — | Filing |
| Sep 11, 2026 | 8-K | 5.02, 9.01 | Director or executive change; Financial statements / exhibits | — | Filing |
| Sep 2, 2026 | 8-K | 1.01, 2.02, 5.02, 7.01, 8.01, 9.01 | Material definitive agreement; Results of operations / financial condition; Director or executive change; Regulation FD disclosure; Other event; Financial statements / exhibits | — | Filing |
| Jul 17, 2026 | 8-K | 5.02 | Director or executive change | — | Filing |
| Jun 24, 2026 | 8-K | 2.02, 7.01, 8.01, 9.01 | Results of operations / financial condition; Regulation FD disclosure; Other event; Financial statements / exhibits | — | Filing |
| May 21, 2026 | 8-K | 5.02, 9.01 | Director or executive change; Financial statements / exhibits | — | Filing |
Period-aligned SEC facts. Comparisons appear only when periods and units are comparable.
| Period | Revenue | YoY |
|---|---|---|
| Ended Aug 1, 2026 | $234.6M | +7.1% |
| Ended Aug 2, 2025 | $219.0M | — |
Dated price context from the historical market series already collected for this security.
Returns are close-to-close price changes. Volatility and drawdown are factual historical context, not recommendations.
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.
| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| Vanguard Group CIK0000102909 | Mar 13, 2026 observed Mar 26, 2026 filed · 13d Schedule 13G amendment | Exit below reporting threshold | 0 -3.7M | 0.00% -7.51 pts | $20.13 | $19.90 | $17.89 |
| Vanguard Group CIK0000102909 | Jun 30, 2025 observed Jul 29, 2025 filed · 29d Initial Schedule 13G | Initial Schedule 13G | 3.7M +1.2M | 7.51% +2.78 pts | $15.12 | $16.78 | $17.89 |
| Vanguard Group CIK0000102909 | Mar 31, 2025 observed Apr 30, 2025 filed · 30d Schedule 13G amendment | Exit below reporting threshold | 2.5M +36.1K | 4.73% -0.50 pts | $12.18 | $12.69 | $17.89 |
Compare DAKT with other securities showing similar institutional activity or recent accumulation across several tracked institutions.